Biotricity Company Insiders

BTCY Stock  USD 1.39  0.06  4.14%   
Biotricity employs about 55 people. The company is managed by 9 executives with a total tenure of roughly 37 years, averaging almost 4.0 years of service per executive, having 6.11 employees per reported executive. Break down of Biotricity's management performance can provide insight into the company performance.
Waqaas AlSiddiq  Chairman
Founder, Chairman, CEO and Executive Officer
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.

Biotricity Management Team Effectiveness

The company has return on total asset (ROA) of (0.9517) % which means that it has lost $0.9517 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (41.0079) %, meaning that it created substantial loss on money invested by shareholders. Biotricity's management efficiency ratios could be used to measure how well Biotricity manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Biotricity's Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to rise to 4.39 in 2024, whereas Return On Tangible Assets are likely to drop (10.49) in 2024. At this time, Biotricity's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 2.2 M in 2024, whereas Total Current Assets are likely to drop slightly above 3.2 M in 2024.
Common Stock Shares Outstanding is likely to drop to about 7.3 M in 2024. Net Loss is likely to rise to about (25.8 M) in 2024

Biotricity Workforce Comparison

Biotricity is number one stock in number of employees category among related companies. The total workforce of Health Care industry is currently estimated at about 95.0. Biotricity totals roughly 55.0 in number of employees claiming about 58% of equities under Health Care industry.

Biotricity Profit Margins

The company has Profit Margin (PM) of (1.25) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.43) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.43.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.330.51
Way Down
Slightly volatile

Biotricity Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Biotricity insiders, such as employees or executives, is commonly permitted as long as it does not rely on Biotricity's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Biotricity insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Biotricity Notable Stakeholders

A Biotricity stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Biotricity often face trade-offs trying to please all of them. Biotricity's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Biotricity's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Waqaas AlSiddiqFounder, Chairman, CEO and Executive OfficerProfile
David RosaIndependent DirectorProfile
Patricia KennedyDirectorProfile
George NikopoulosDirector DevelopmentProfile
Norman BettsIndependent DirectorProfile
Amir AliChief OfficerProfile
John AyanoglouChief OfficerProfile
Andy WongVice OperationsProfile
Matt ZabelVice StrategyProfile

About Biotricity Management Performance

The success or failure of an entity such as Biotricity often depends on how effective the management is. Biotricity management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Biotricity management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Biotricity management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(9.99)(10.49)
Return On Capital Employed 4.14  4.35 
Return On Assets(9.99)(10.49)
Return On Equity 4.18  4.39 
The data published in Biotricity's official financial statements usually reflect Biotricity's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Biotricity. For example, before you start analyzing numbers published by Biotricity accountants, it's critical to develop an understanding of what Biotricity's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Biotricity's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biotricity's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Biotricity's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Biotricity. Please utilize our Beneish M Score to check the likelihood of Biotricity's management manipulating its earnings.

Biotricity Workforce Analysis

Traditionally, organizations such as Biotricity use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Biotricity within its industry.

Biotricity Manpower Efficiency

Return on Biotricity Manpower

Revenue Per Employee175.3K
Revenue Per Executive1.1M
Net Loss Per Employee339.2K
Net Loss Per Executive2.1M
When determining whether Biotricity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biotricity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biotricity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biotricity Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.
Note that the Biotricity information on this page should be used as a complementary analysis to other Biotricity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for Biotricity Stock analysis

When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Money Managers
Screen money managers from public funds and ETFs managed around the world
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Stocks Directory
Find actively traded stocks across global markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Is Biotricity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biotricity. If investors know Biotricity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biotricity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.75)
Revenue Per Share
1.319
Quarterly Revenue Growth
0.209
Return On Assets
(0.95)
Return On Equity
(41.01)
The market value of Biotricity is measured differently than its book value, which is the value of Biotricity that is recorded on the company's balance sheet. Investors also form their own opinion of Biotricity's value that differs from its market value or its book value, called intrinsic value, which is Biotricity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biotricity's market value can be influenced by many factors that don't directly affect Biotricity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biotricity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotricity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotricity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.